FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) submitted by Fresenius Medical Care Renal Therapies Group, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• VELPHORO (sucroferric oxyhydroxide)

Snippet

SUPPL AP for VELPHORO (SUCROFERRIC OXYHYDROXIDE)